Drug for Fungal Infections in Lung Transplant Recipients Increases Risk for Skin Cancer, Even Death
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.